Bicalutamide tablets 50 mg

Bicalutamide tablets 50 mg
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide tablets 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Bendamustin hcl

    Product Bendamustin hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustin hcl. It belongs to antineoplastic apis category. Contact us for more information.
  • Bendamustine 100 mg*

    Product Bendamustine 100 mg*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustine 100 mg*. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Besifloxacin

    Product Besifloxacin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes besifloxacin. It belongs to quinolone apis products category. Contact us for more information.
  • Biapenem 300 mg / 600 mg* --- under development

    Product Biapenem 300 mg / 600 mg* --- under development

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem 300 mg / 600 mg* --- under development. It belobgs to carbapenem finish formulations products category. Contact us for more information.
  • Biapenem*

    Product Biapenem*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem*. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.
  • Bicalutamide

    Product Bicalutamide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide. It belongs to antineoplastic apis category. Contact us for more information.
  • Bimatoprost

    Product Bimatoprost

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bimatoprost. It belongs to antiglaucoma apis products category. Contact us for more information.
  • Bivalirudin

    Product Bivalirudin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin. It belongs to anticoagulant apis category. Contact us for more information.
  • Bivalirudin 250 mg inj

    Product Bivalirudin 250 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin 250 mg inj. It belongs to cardiac finish formulations products category. Contact us for more information.
  • Bleomycin sulphate 15 mg

    Product Bleomycin sulphate 15 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bleomycin sulphate 15 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Bortezomib

    Product Bortezomib

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib. It belongs to antineoplastic apis category. Contact us for more information.
  • Bortezomib 2 mg/ 3.5 mg

    Product Bortezomib 2 mg/ 3.5 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib 2 mg/ 3.5 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)